Theravance Biopharma Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$14.33

+0.32 (+2.28%)

As of Mar 22, 10:12 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 77%

Hold 3 23%

Sell 0 0%

Price Target

Analyst Price Target +74.1% upside

Low Target $16.23

Average Target $24.95

High Target $30.59

Current Price $14.33

Current
$14.33

Target
$24.95

$16.23 $24.95 avg $30.59

Scenario Analysis

Bear Case

$16.23

13.3%

Low target

Base Case

$24.95

+74.1%

Avg target

Bull Case

$30.59

+113.5%

High target

Risk/Reward

8.6x

Highly favorable

Price in Context

52-Week High

$21.03

-31.9% from high

52-Week Low

$7.90

+81.4% from low

Target vs 52W High

$24.95

+18.6% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%